Report Detail

Other Global Extended Release Drug Market Size, Status and Forecast 2019-2025

  • RnM3819843
  • |
  • 07 November, 2019
  • |
  • Global
  • |
  • 95 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Extended Release Drug Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Sustained Release Drug
      • 1.4.3 Controlled Release Drug
    • 1.5 Market by Application
      • 1.5.1 Global Extended Release Drug Market Share by Application (2019-2025)
      • 1.5.2 Hospital Pharmacy
      • 1.5.3 Retail Pharmacy
      • 1.5.4 Online Pharmacy
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Extended Release Drug Market Size
    • 2.2 Extended Release Drug Growth Trends by Regions
      • 2.2.1 Extended Release Drug Market Size by Regions (2019-2025)
      • 2.2.2 Extended Release Drug Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Extended Release Drug Market Size by by Players
      • 3.1.1 Global Extended Release Drug Revenue by by Players (2014-2019)
      • 3.1.2 Global Extended Release Drug Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Extended Release Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Extended Release Drug Key Players Head office and Area Served
    • 3.3 Key Players Extended Release Drug Product/Solution/Service
    • 3.4 Date of Enter into Extended Release Drug Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Extended Release Drug Market Size by Type (2014-2019)
    • 4.2 Global Extended Release Drug Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Extended Release Drug Market Size (2014-2019)
    • 5.2 Extended Release Drug Key Players in North America
    • 5.3 North America Extended Release Drug Market Size by Type
    • 5.4 North America Extended Release Drug Market Size by Application

    6 Europe

    • 6.1 Europe Extended Release Drug Market Size (2014-2019)
    • 6.2 Extended Release Drug Key Players in Europe
    • 6.3 Europe Extended Release Drug Market Size by Type
    • 6.4 Europe Extended Release Drug Market Size by Application

    7 Asia-Pacific

    • 7.1 Asia-Pacific Extended Release Drug Market Size (2014-2019)
    • 7.2 Extended Release Drug Key Players in Asia-Pacific
    • 7.3 Asia-Pacific Extended Release Drug Market Size by Type
    • 7.4 Asia-Pacific Extended Release Drug Market Size by Application

    8 International Players Profiles

    • 8.1 Pfizer
      • 8.1.1 Pfizer Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Extended Release Drug Introduction
      • 8.1.4 Pfizer Revenue in Extended Release Drug Business (2014-2019))
      • 8.1.5 Pfizer Recent Development
    • 8.2 Mallinckrodt
      • 8.2.1 Mallinckrodt Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Extended Release Drug Introduction
      • 8.2.4 Mallinckrodt Revenue in Extended Release Drug Business (2014-2019)
      • 8.2.5 Mallinckrodt Recent Development
    • 8.3 Teva
      • 8.3.1 Teva Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Extended Release Drug Introduction
      • 8.3.4 Teva Revenue in Extended Release Drug Business (2014-2019)
      • 8.3.5 Teva Recent Development
    • 8.4 Johnson & Johnson
      • 8.4.1 Johnson & Johnson Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Extended Release Drug Introduction
      • 8.4.4 Johnson & Johnson Revenue in Extended Release Drug Business (2014-2019)
      • 8.4.5 Johnson & Johnson Recent Development
    • 8.5 Endo Pharmaceuticals
      • 8.5.1 Endo Pharmaceuticals Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Extended Release Drug Introduction
      • 8.5.4 Endo Pharmaceuticals Revenue in Extended Release Drug Business (2014-2019)
      • 8.5.5 Endo Pharmaceuticals Recent Development
    • 8.6 Purdue Pharma
      • 8.6.1 Purdue Pharma Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Extended Release Drug Introduction
      • 8.6.4 Purdue Pharma Revenue in Extended Release Drug Business (2014-2019)
      • 8.6.5 Purdue Pharma Recent Development
    • 8.7 Mylan
      • 8.7.1 Mylan Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Extended Release Drug Introduction
      • 8.7.4 Mylan Revenue in Extended Release Drug Business (2014-2019)
      • 8.7.5 Mylan Recent Development
    • 8.8 Hisamitsu Pharmaceutical
      • 8.8.1 Hisamitsu Pharmaceutical Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Extended Release Drug Introduction
      • 8.8.4 Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2014-2019)
      • 8.8.5 Hisamitsu Pharmaceutical Recent Development
    • 8.9 Sun Pharmaceutical Industries
      • 8.9.1 Sun Pharmaceutical Industries Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Extended Release Drug Introduction
      • 8.9.4 Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2014-2019)
      • 8.9.5 Sun Pharmaceutical Industries Recent Development

    9 Market Forecast 2019-2025

    • 9.1 Market Size Forecast by Product (2019-2025)
    • 9.2 Market Size Forecast by Application (2019-2025)
    • 9.3 Market Size Forecast by Regions
    • 9.4 North America
    • 9.5 Europe
    • 9.6 Asia-Pacific

    10 Analyst's Viewpoints/Conclusions

      11 Appendix

      • 11.1 Research Methodology
        • 11.1.1 Methodology/Research Approach
          • 11.1.1.1 Research Programs/Design
          • 11.1.1.2 Market Size Estimation
          • 11.1.1.3 Market Breakdown and Data Triangulation
        • 11.1.2 Data Source
          • 11.1.2.1 Secondary Sources
          • 11.1.2.2 Primary Sources
      • 11.2 Disclaimer

      This report focuses on the global Extended Release Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Extended Release Drug development in North America, Europe and Asia-Pacific.

      The key players covered in this study
      Pfizer
      Mallinckrodt
      Teva
      Johnson & Johnson
      Endo Pharmaceuticals
      Purdue Pharma
      Mylan
      Hisamitsu Pharmaceutical
      Sun Pharmaceutical Industries

      Market segment by Type, the product can be split into
      Sustained Release Drug
      Controlled Release Drug

      Market segment by Application, split into
      Hospital Pharmacy
      Retail Pharmacy
      Online Pharmacy

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      Asia-Pacific

      The study objectives of this report are:
      To analyze global Extended Release Drug status, future forecast, growth opportunity, key market and key players.
      To present the Extended Release Drug development in North America, Europe and Asia-Pacific.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Extended Release Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Extended Release Drug. Industry analysis & Market Report on Extended Release Drug is a syndicated market report, published as Global Extended Release Drug Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Extended Release Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,040.72
      4,561.09
      6,081.45
      3,535.85
      5,303.77
      7,071.70
      425,579.70
      638,369.55
      851,159.40
      278,394.87
      417,592.31
      556,789.74
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report